| RS312262784 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Inborn genetic diseases |
| RS312262785 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS312262786 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 11, SPG11-related disorder |
| RS312262787 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia |
| RS312262788 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Amyotrophic lateral sclerosis type 5 |
| RS312262791 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS312262798 |
NOTCH2
|
Health Risk |
Pathogenic |
Alagille syndrome due to a NOTCH2 point mutation, Alagille syndrome due to a NOTCH2 point mutation |
| RS312262801 |
NOTCH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hajdu-Cheney syndrome, Inborn genetic diseases |
| RS312262803 |
SACK1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Amelogenesis imperfecta, hypocalcification type |
| RS312262809 |
OFD1
|
Health Risk |
Pathogenic |
Joubert syndrome, Orofaciodigital syndrome I |
| RS312262810 |
OFD1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome I, Joubert syndrome |
| RS312262811 |
OFD1
|
Health Risk |
Pathogenic |
— |
| RS312262818 |
OFD1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome I, Joubert syndrome |
| RS312262821 |
OFD1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome I, Orofaciodigital syndrome I |
| RS312262822 |
OFD1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome I, Orofaciodigital syndrome I |
| RS312262830 |
OFD1
|
Health Risk |
Pathogenic |
Joubert syndrome 10, Simpson-Golabi-Behmel syndrome type 2 |
| RS312262833 |
OFD1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome I, Orofaciodigital syndrome I |
| RS312262834 |
OFD1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome I, Orofaciodigital syndrome I |
| RS312262840 |
OFD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Orofaciodigital syndrome I |
| RS312262845 |
OFD1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome I, Joubert syndrome |
| RS312262852 |
OFD1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome I, Orofaciodigital syndrome I |
| RS312262858 |
OFD1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome I, Joubert syndrome |
| RS312262863 |
OFD1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome I, Joubert syndrome |
| RS312262868 |
OFD1
|
Health Risk |
Pathogenic |
Joubert syndrome 10, Simpson-Golabi-Behmel syndrome type 2 |
| RS312262869 |
OFD1
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Orofaciodigital syndrome I |
| RS312262871 |
OFD1
|
Health Risk |
Pathogenic |
OFD1-related disorder, Orofaciodigital syndrome I |
| RS312262886 |
OFD1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome I, Orofaciodigital syndrome I |
| RS312262887 |
OFD1
|
Health Risk |
Pathogenic |
Orofaciodigital syndrome I, Orofaciodigital syndrome I |
| RS312262890 |
OFD1
|
Health Risk |
Pathogenic |
Simpson-Golabi-Behmel syndrome type 2, Orofaciodigital syndrome I |
| RS312262894 |
OFD1
|
Health Risk |
Pathogenic |
Joubert syndrome 10, Joubert syndrome 10 |
| RS312262895 |
OFD1
|
Health Risk |
Pathogenic |
Joubert syndrome 10, Joubert syndrome 10 |
| RS312262900 |
COMP
|
Health Risk |
Pathogenic |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Carpal tunnel syndrome 2 |
| RS312262901 |
COMP
|
Health Risk |
Pathogenic/Likely pathogenic |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS312262902 |
COMP
|
Health Risk |
Likely pathogenic |
— |
| RS312262903 |
COMP
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 1, Multiple epiphyseal dysplasia type 1 |
| RS312262904 |
COMP
|
Health Risk |
Likely pathogenic |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS3126141 |
RP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS3127334 |
TBXT
|
Health Risk |
risk factor |
Neural tube defects, susceptibility to |
| RS3129202 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fibrochondrogenesis 2, Otospondylomegaepiphyseal dysplasia |
| RS3134940 |
AGER
|
Health Risk |
Likely risk allele |
COPD, severe early onset |
| RS3135755 |
FGFR2
|
Health Risk |
Conflicting classifications of pathogenicity |
FGFR2-related craniosynostosis, FGFR2-related craniosynostosis |
| RS3136092 |
ERCC4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cockayne syndrome, Xeroderma pigmentosum |
| RS3136151 |
ERCC4
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group F |
| RS3136334 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome |
| RS3136351 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS3136532 |
F2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital prothrombin deficiency, Inborn genetic diseases |
| RS3153 |
IFNAR2
|
Health Risk |
Uncertain significance; association |
Mortality risk in patients with severe coronavirus disease (COVID-19), Associated with severe COVID-19 disease |
| RS3169258 |
APRT
|
Health Risk |
Pathogenic |
Adenine phosphoribosyltransferase deficiency, Adenine phosphoribosyltransferase deficiency |
| RS3169548 |
ALDOA
|
Health Risk |
Conflicting classifications of pathogenicity |
HNSHA due to aldolase A deficiency, HNSHA due to aldolase A deficiency |
| RS3176124 |
THBD
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with thrombomodulin anomaly, Atypical hemolytic-uremic syndrome with thrombomodulin anomaly |
| RS3176179 |
POLG
|
Health Risk |
Pathogenic |
POLG-related disorder, Progressive sclerosing poliodystrophy |
| RS3180234 |
IL36RN
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized pustular psoriasis, Acrodermatitis continua suppurativa of Hallopeau |
| RS3180235 |
IL36RN
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized pustular psoriasis, Acrodermatitis continua suppurativa of Hallopeau |
| RS3180383 |
GALE
|
Health Risk |
Pathogenic |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS3180515 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Danon disease |
| RS3181540 |
SDHA
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Pheochromocytoma/paraganglioma syndrome 5 |
| RS318240735 |
TTBK2
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 11, Spinocerebellar ataxia type 11 |
| RS318240750 |
CDKN1C
|
Health Risk |
Pathogenic |
IMAGe syndrome, Silver-Russell syndrome 1 |
| RS318240757 |
RTTN
|
Health Risk |
Pathogenic |
MICROCEPHALY, SHORT STATURE |
| RS318240758 |
HCFC1
|
Health Risk |
Pathogenic |
Methylmalonic acidemia with homocystinuria, type cblX |
| RS318240759 |
WNT10A
|
Health Risk |
Pathogenic/Likely pathogenic |
Schöpf-Schulz-Passarge syndrome, Odonto-onycho-dermal dysplasia |
| RS318240761 |
WDR11
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 14 with anosmia, Hypogonadotropic hypogonadism 14 with anosmia |
| RS318240762 |
BMP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type 13, Abnormality of the skeletal system |
| RS319443 |
ATP8B1
|
Health Risk |
Pathogenic |
Benign recurrent intrahepatic cholestasis type 1, Benign recurrent intrahepatic cholestasis type 1 |
| RS3203621 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS3205509 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS3205809 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS3206694 |
TUBA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
TUBA1A-related disorder, TUBA1A-related disorder |
| RS3207617 |
HNRNPA1
|
Health Risk |
Likely pathogenic |
Relapsing remitting multiple sclerosis, Relapsing remitting multiple sclerosis |
| RS3209663 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 4 |
| RS3210083 |
NDUFA9
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 26 |
| RS3210462 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS3211893 |
CD36
|
Health Risk |
Conflicting classifications of pathogenicity |
Platelet-type bleeding disorder 10, Coronary heart disease |
| RS3211901 |
CD36
|
Health Risk |
Likely pathogenic |
Platelet-type bleeding disorder 10, Coronary heart disease |
| RS3211938 |
CD36
|
Health Risk |
Conflicting classifications of pathogenicity |
Platelet-type bleeding disorder 10, Malaria |
| RS3212716 |
JAK3
|
Health Risk |
Conflicting classifications of pathogenicity |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS3212977 |
ERCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebrooculofacioskeletal syndrome 4, ERCC1-related disorder |
| RS3213408 |
JAK3
|
Health Risk |
Conflicting classifications of pathogenicity |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS3216174 |
G6PD
|
Health Risk |
Conflicting classifications of pathogenicity |
Anemia, nonspherocytic hemolytic |
| RS3217992 |
CDKN2B
|
Health Risk |
Likely pathogenic |
Malignant tumor of breast, Malignant tumor of breast |
| RS3218537 |
XRCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group U |
| RS3218597 |
REV3L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS3218670 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS3218684 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS3218690 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS3218699 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS3218708 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS3218713 |
MYH7
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS3218714 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy |
| RS3218716 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 1 |
| RS3218727 |
CDT1
|
Health Risk |
Conflicting classifications of pathogenicity |
CDT1-related disorder, Inborn genetic diseases |
| RS3218740 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia-like disorder 1 |
| RS3218750 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS3218758 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS3218773 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS3218775 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS3219018 |
FCGR2B
|
Health Risk |
risk factor |
Systemic lupus erythematosus, susceptibility to |
| RS3219160 |
ALS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 2, juvenile |
| RS3219166 |
ALS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile-onset ascending hereditary spastic paralysis, ALS2-related disorder |
| RS3219457 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |